US 6071949
Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
expired A61KA61K31/40
Quick answer
US patent 6071949 (Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/40